IGF2BP1 and hepatocellular carcinoma: Moreover, IGF2BP1 facilitates the translation of circMAP3K4 into a novel peptide, circMAP3K4-455aa, which blocks the apoptosis of HCC cells by inhibiting the cleavage and nuclear distribution of the mitochondria-associated apoptosis-inducing factor 1 (AIF) 50.